The Far-Reaching Impacts of the CONVINCE Study
Dr. Dominik K. Heger
![Dr. Dominik K. Heger]()
Dr. Dominik K. Heger
Head of Investor Relations, Strategic Development, Communications | Executive Vice President | Certified Independent Board Director by Deutsche Boerse
When researchers began the CONVINCE Study, initial results of which were published in June 2023 in the New England Journal of Medicine, they sought to find ways to quantify the benefits patients might receive using high-volume hemodiafiltration (HDF) as compared to the standard of care, hemodialysis. Not only were the results promising with regards to HDF as a treatment method in reducing mortality rates, they also showed the unique role patient-reported outcomes (PROs) can play in medical studies for kidney patients and beyond.
If you’re looking for more personalized support on integrating high-volume HDF into your practice, feel free to reach out. Our team at User Experience Researchers offers expertise in healthcare UX solutions that can help enhance patient care and streamline implementation. Check out our services and get in touch!